Compare Moderna, Inc. (MRNA) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Schlumberger NV — how do they compare? Moderna, Inc. trades at $60.77 (market cap $24.18B), while Schlumberger NV trades at $53.7 (market cap $79.67B). The key difference: Schlumberger NV is far larger — about 3.3× Moderna, Inc.'s market cap, and Schlumberger NV pays a 2.2% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | SLB | |
|---|---|---|
Market Cap | $24.18B | $79.67B |
Sector | Health | Energy |
52-Week High | $81.80 | $58.01 |
52-Week Low | $22.36 | $31.72 |
Enterprise Value | $20.33B | $88.40B |
Dividend Yield | — | 2.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
